The latest report by IMARC Group, titled “Aminoglycosides Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032“, The global aminoglycosides market size reached US$ 1.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.1 Billion by 2032, exhibiting a growth rate (CAGR) of 2.66% during 2024-2032.
Aminoglycosides are a class of antibiotics widely used in the field of medicine. These antibiotics are renowned for their effectiveness against a variety of bacterial infections. Aminoglycosides function by inhibiting bacterial protein synthesis, which ultimately leads to the disruption of bacterial growth and reproduction. They are particularly valuable in treating severe infections caused by Gram-negative bacteria, including those resistant to other classes of antibiotics. Due to their potent bactericidal properties, aminoglycosides are often employed in hospital settings to combat infections related to surgery, burns, or critical illnesses.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/aminoglycosides-market/requestsample
Aminoglycosides Market Trends and Drivers:
The persistent prevalence of bacterial infections, especially those caused by Gram-negative bacteria, fuels the demand for aminoglycosides. These antibiotics are highly effective against a range of infections, from urinary tract infections to severe respiratory conditions. Additionally, the emergence of antibiotic-resistant strains of bacteria underscores the need for potent antibiotics like aminoglycosides. As some bacteria become resistant to other antibiotics, aminoglycosides remain effective treatment options, driving their demand. Other than this, aminoglycosides play a crucial role in managing hospital-acquired infections due to their broad-spectrum activity. In intensive care units and surgical wards, where such infections pose significant challenges, the demand for these antibiotics is consistently high. Besides this, with an aging global population, there is a higher susceptibility to infections and related complications. Aminoglycosides find substantial use in treating elderly patients with compromised immune systems, driving market expansion. Moreover, ongoing research has led to the development of improved formulations that enhance the efficacy and safety of aminoglycosides. These advancements expand their application in diverse medical scenarios, contributing to market growth.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Product:
- Neomycin
- Tobramycin
- Gentamicin
- Amikacin
- Paromomycin
- Streptomycin
- Kanamycin
- Others
Breakup by Application:
- Veterinary
- Skin Infection
- Respiratory Diseases
- UTI and Pelvic Diseases
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Huvepharma NV
- Kremoint Pharma Pvt. Ltd.
- Novartis AG
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd
- Vega Group company limited
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 |United Kingdom: +44-753-713-2163
